Jennison Associates’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-14,167
| Closed | -$16.9M | – | 657 |
|
|
2019
Q2 | $16.9M | Sell |
14,167
-68
| -0.5% | -$81.1K | 0.02% | 377 |
|
|
2019
Q1 | $17.7M | Buy |
14,235
+14
| +0.1% | +$17.4K | 0.02% | 374 |
|
|
2018
Q4 | $13.5M | Sell |
14,221
-767
| -5% | -$726K | 0.02% | 404 |
|
|
2018
Q3 | $21.6M | Sell |
14,988
-951
| -6% | -$1.37M | 0.02% | 386 |
|
|
2018
Q2 | $25.7M | Buy |
15,939
+263
| +2% | +$424K | 0.03% | 362 |
|
|
2018
Q1 | $25.4M | Sell |
15,676
-202
| -1% | -$328K | 0.03% | 357 |
|
|
2017
Q4 | $26.7M | Sell |
15,878
-24
| -0.2% | -$40.3K | 0.03% | 360 |
|
|
2017
Q3 | $22.2M | Sell |
15,902
-35
| -0.2% | -$49K | 0.02% | 392 |
|
|
2017
Q2 | $17.8M | Buy |
+15,937
| New | +$17.8M | 0.02% | 422 |
|